UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000044513
Receipt No. R000050833
Scientific Title A study for effects on body surface temperature and feeling of "Ninnikushoga" intake under cool conditions in healthy adult female who are concerned about cold.
Date of disclosure of the study information 2021/06/13
Last modified on 2021/10/29 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title A study for effects on body surface temperature and feeling of "Ninnikushoga" intake under cool conditions in healthy adult female who are concerned about cold.
Acronym A study for effects on body surface temperature and feeling of "Ninnikushoga" intake under cool conditions in healthy adult female who are concerned about cold.
Scientific Title A study for effects on body surface temperature and feeling of "Ninnikushoga" intake under cool conditions in healthy adult female who are concerned about cold.
Scientific Title:Acronym A study for effects on body surface temperature and feeling of "Ninnikushoga" intake under cool conditions in healthy adult female who are concerned about cold.
Region
Japan

Condition
Condition Healthy adult
Classification by specialty
Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate the effects on body surface temperature and feeling of "Ninnikushoga" intake under cool conditions.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Area under the curve of body surface temperature
Key secondary outcomes Body surface temperature
Autonomic function
Subjective symptoms questionnaire

Base
Study type Interventional

Study design
Basic design Cross-over
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Prevention
Type of intervention
Food
Interventions/Control_1 Intake of test food (single ingestion) - washing out (a day or more) - intake of placebo (single ingestion)
Interventions/Control_2 Intake of placebo (single ingestion) - washing out (a day or more) - intake of test food (single ingestion)
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
64 years-old >=
Gender Female
Key inclusion criteria (1)Healthy females from 20 to 64 years of age
(2)Subjects who are aware of getting cold of fingers under air conditioner working
(3)Subjects who live an ordered life
(4)Subjects who drop body surface temperature under cool conditions on preliminary examination
Key exclusion criteria (1)Subjects who have been diagnosed underlying disease accompanied with angiopathy (e.g. arteriosclerosis obliterans, arteritis obliterans, collagen disease and diabetes, etc.)
(2)Subjects who constantly take medicines affecting the skin surface temperature(e.g. warfarin)
(3)Subjects who eat food for specified health or health food affecting the skin surface temperature(e.g. healthy food including garlic or ginger) at least once a week
(4)Subjects having food allergy
(5)Subjects who are smokers or have smoked within the past 3 months
(6)Subjects who have a scar affecting the skin surface temperature and autonomic function on fingers, palms, toes and insteps
(7)Subjects who have worked shifts day and night or are planned to work shifts day and night from a month before obtaining the consent for this study to the date of the completion this study
(8)Subjects who have gone abroad or are planned to go abroad from a month before obtaining the consent for this study to the date of the completion this study
(9)Subjects who have participated in other clinical study within the last one month prior to the current study or are planned to participate in other clinical study after informed consent for the current study
(10)Subjects who intend to become pregnant or lactating during the study
(11)Subjects having a disease requiring treatment or taking medicines
(12)Subjects having a history of serious diseases
(13)Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire
(14)Subjects who are not judged as healthy based on the results of clinical and physical examination on preliminary examination
(15)Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on preliminary examination
Target sample size 16

Research contact person
Name of lead principal investigator
1st name Yasushi
Middle name
Last name Nakasone
Organization Kenkoukazoku Co., Ltd.
Division name None
Zip code 892-0848
Address 10-2, Hirano-cho, Kagoshima-shi, Kagoshima, 892-0848, JAPAN
TEL 099-223-5211
Email yasushi.nakasone@kenkoukazoku.co.jp

Public contact
Name of contact person
1st name Yoshimi
Middle name
Last name Bansho
Organization EP Mediate Co., Ltd.
Division name Development Business Headquarters, TTC Center, Trial Planning Department
Zip code 162-0822
Address Tsuruya Bldg.,2-23, Shimomiyabicho, Shinjuku-ku, Tokyo
TEL 03-5657-4983
Homepage URL
Email bansho189@eps.co.jp

Sponsor
Institute EP Mediate Co., Ltd.
Institute
Department

Funding Source
Organization Kenkoukazoku Co., Ltd.
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Medical Station Clinic Research Ethics Committee
Address 3-12-8, Takaban, Meguroku, Tokyo
Tel 080-2290-2544
Email makabe295@eps.co.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2021 Year 06 Month 13 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2021 Year 06 Month 10 Day
Date of IRB
2021 Year 06 Month 10 Day
Anticipated trial start date
2021 Year 06 Month 14 Day
Last follow-up date
2021 Year 07 Month 22 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2021 Year 06 Month 11 Day
Last modified on
2021 Year 10 Month 29 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050833